Literature DB >> 10864899

Involvement of tyrosine phosphorylation in the positive inotropic effect produced by H(1)-receptors with histamine in guinea-pig left atrium.

Y Akaishi1, Y Hattori, K Yoshimoto, A Kitabatake, K Yasuda, M Kanno.   

Abstract

We investigated the effect of stimulation of H(1)-receptors with histamine on protein tyrosine phosphorylation levels in guinea-pig left atrium and evaluated the influences of tyrosine kinase inhibitors on the positive inotropic effect mediated by H(1)-receptors in this tissue. Histamine induced an increase in tyrosine phosphorylation in four main clusters of proteins with apparent molecular weights of 25, 35, 65 and 150 kDa. Tyrosine phosphorylation of these proteins attained a peak around 2 - 3 min following histamine stimulation and then declined to or below basal levels. Histamine-induced protein tyrosine phosphorylation was antagonized by the H(1)-receptor antagonists mepyramine (1 microM) and chlorpheniramine (1 microM), but not by the H(2)-receptor antagonist cimetidine (10 microM). The positive inotropic effect of histamine was depressed in a concentration-dependent manner by the tyrosine kinase inhibitors tyrphostin A25 (50 to 100 microM) and genistein (10 to 50 microM) but not by the inactive genistein analogue daidzein (50 microM). The positive inotropic effect of isoprenaline was unchanged by tyrphostin A25 and genistein. At a concentration of 1 microM histamine produced a dual-component positive inotropic response composed of an initial increasing phase and a second and late developing, greater positive inotropic phase. Treatment with tyrphostin A25 (100 microM) and genistein (50 microM), but not daidzein (50 microM), significantly attenuated the two components of the inotropic response, although genistein suppressed the initial component more markedly than the late component. We conclude that increased protein tyrosine phosphorylation may play an important role in initiating at least some part of the positive inotropic effect of H(1)-receptor stimulation in guinea-pig left atrium.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10864899      PMCID: PMC1572121          DOI: 10.1038/sj.bjp.0703355

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  43 in total

1.  pp60c-src increases voltage-operated calcium channel currents in vascular smooth muscle cells.

Authors:  S Wijetunge; A D Hughes
Journal:  Biochem Biophys Res Commun       Date:  1995-12-26       Impact factor: 3.575

2.  Inhibition of vascular smooth muscle cell K+ currents by tyrosine kinase inhibitors genistein and ST 638.

Authors:  S V Smirnov; P I Aaronson
Journal:  Circ Res       Date:  1995-02       Impact factor: 17.367

3.  Histamine receptors mediating a positive inotropic effect in guinea pig and rabbit ventricular myocardium: distribution of the receptors and their possible intracellular coupling processes.

Authors:  Y Hattori; S Gando; M Nagashima; M Kanno
Journal:  Jpn J Pharmacol       Date:  1994-08

4.  Cloning and expression of fibroblast growth factor receptor-1 isoforms in the mouse heart: evidence for isoform switching during heart development.

Authors:  Y Jin; K B Pasumarthi; M E Bock; A Lytras; E Kardami; P A Cattini
Journal:  J Mol Cell Cardiol       Date:  1994-11       Impact factor: 5.000

Review 5.  Tyrosine kinase pathways and the regulation of smooth muscle contractility.

Authors:  M D Hollenberg
Journal:  Trends Pharmacol Sci       Date:  1994-04       Impact factor: 14.819

6.  Tyrphostin attenuates platelet-derived growth factor-induced contraction in aortic smooth muscle through inhibition of protein tyrosine kinase(s).

Authors:  M D Sauro; B Thomas
Journal:  J Pharmacol Exp Ther       Date:  1993-12       Impact factor: 4.030

7.  The heterotrimeric G q protein-coupled angiotensin II receptor activates p21 ras via the tyrosine kinase-Shc-Grb2-Sos pathway in cardiac myocytes.

Authors:  J Sadoshima; S Izumo
Journal:  EMBO J       Date:  1996-02-15       Impact factor: 11.598

8.  The tyrosine kinase inhibitor, genistein, prevents alpha-adrenergic-induced cardiac muscle cell hypertrophy by inhibiting activation of the Ras-MAP kinase signaling pathway.

Authors:  J Thorburn; A Thorburn
Journal:  Biochem Biophys Res Commun       Date:  1994-08-15       Impact factor: 3.575

9.  Inhibition of L-type calcium current in rat ventricular cells by the tyrosine kinase inhibitor, genistein and its inactive analog, daidzein.

Authors:  H Yokoshiki; K Sumii; N Sperelakis
Journal:  J Mol Cell Cardiol       Date:  1996-04       Impact factor: 5.000

10.  Adult cardiomyocytes express functional high-affinity receptors for basic fibroblast growth factor.

Authors:  L Liu; K B Pasumarthi; R R Padua; H Massaeli; R R Fandrich; G N Pierce; P A Cattini; E Kardami
Journal:  Am J Physiol       Date:  1995-05
View more
  3 in total

1.  Efficacy of antihistamines on mortality in patients receiving maintenance hemodialysis: an observational study using propensity score matching.

Authors:  Kiyotsugu Omae; Masao Yoshikawa; Hiroshi Sakura; Kosaku Nitta; Tetsuya Ogawa
Journal:  Heart Vessels       Date:  2017-05-16       Impact factor: 2.037

2.  Differential action of a protein tyrosine kinase inhibitor, genistein, on the positive inotropic effect of endothelin-1 and norepinephrine in canine ventricular myocardium.

Authors:  Li Chu; Jian-Xin Zhang; Ikuo Norota; Masao Endoh
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

Review 3.  The Roles of Cardiovascular H2-Histamine Receptors Under Normal and Pathophysiological Conditions.

Authors:  Joachim Neumann; Uwe Kirchhefer; Stefan Dhein; Britt Hofmann; Ulrich Gergs
Journal:  Front Pharmacol       Date:  2021-12-20       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.